FDA Panel Says AstraZeneca Warned on Drug Study (Reuters)


Reuters - AstraZeneca Plc has done a
good job of warning doctors about a study showing its drug
Iressa did not extend survival of advanced lung cancer
patients, a U.S. advisory panel said on Friday as regulators
weigh the drug's future.

Read more...